Wambui Machua
Experienced in Systemic Sclerosis (SSc)

Dr. Wambui Machua

Rheumatology
Piedmont Healthcare
Piedmont Physicians Rheumatology Atlanta
1800 Howell Mill Road, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Experienced in Systemic Sclerosis (SSc)
Piedmont Healthcare
Piedmont Physicians Rheumatology Atlanta
1800 Howell Mill Road, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Wambui Machua, M.D., completed her residency and fellowship training at Morehouse School of Medicine and Medical College of Georgia respectively. Prior to joining Piedmont, Dr. Machua was previously involved in multiple clinical trials in the Atlanta area. She is a member of the American College of Rheumatology, International Society for Clinical Densitometry and board certified in internal medicine. She serves on the Lupus Foundation of America, Georgia chapter, Medical Advisory Board. Dr. Machua believes medicine brings healing through collaboration between the patient and the medical provider team. She provides compassionate, patient-centered care and utilizes cutting edge therapies and holistic care to manage rheumatic diseases. She is a strong advocate for her patients. In her free time, Dr. Machua enjoys spending time with family and friends, walking and cooking. Dr. Machua welcomes new patients and accepts most insurance plans.

Dr. Machua is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Lupus Nephritis, and Cutaneous Lupus Erythematosus (CLE).

Her clinical research consists of co-authoring 6 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
American University Of Integrative Sciences/ University Of Sint Eustatius, 2008
Residency
Morehouse School of Medicine, Internal Medicine, 2013
Specialties
Rheumatology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine - Rheumatology
Fellowships
Augusta University (formerly Georgia Regents Medical Center), Rheumatology, 2015
Hospital Affiliations
Piedmont Hospital, Inc
Languages Spoken
English
Kiswahili
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Piedmont Physicians Rheumatology Atlanta
1800 Howell Mill Road, Atlanta, GA 30318
Call: 404-367-3350

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

6 Total Publications

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.
A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.
Journal: Arthritis care & research
Published: June 26, 2025
View All 6 Publications
Similar Doctors
Katina C. Tsagaris
Distinguished in Systemic Sclerosis (SSc)
Dr. Katina C. Tsagaris
Rheumatology
Distinguished in Systemic Sclerosis (SSc)
Dr. Katina C. Tsagaris
Rheumatology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (4.0 miles away)
404-778-4366
Experience:
17+ years
Languages Spoken:
English, Greek
See accepted insurances
Offers Telehealth

Katina Tsagaris is a Rheumatologist in Atlanta, Georgia. Dr. Tsagaris has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Scleredema, Systemic Sclerosis (SSc), Scleroma, and Scleroderma.

Advanced in Systemic Sclerosis (SSc)
Dr. Mohammad Kamran
Rheumatology
Advanced in Systemic Sclerosis (SSc)
Dr. Mohammad Kamran
Rheumatology

Wellstar Medical Group LLC

677 Church St Ne, Suite 100p, 
Marietta, GA 
 (14.2 miles away)
470-793-8585
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients
Offers Telehealth

Mohammad Kamran is a Rheumatologist in Marietta, Georgia. Dr. Kamran is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Dermatomyositis, and Gout. Dr. Kamran is currently accepting new patients.

Advanced in Systemic Sclerosis (SSc)
Dr. Mala S. Kaul
Rheumatology
Advanced in Systemic Sclerosis (SSc)
Dr. Mala S. Kaul
Rheumatology
2727 Paces Ferry Rd Se, Suite 1 1100, 
Atlanta, GA 
 (6.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mala Kaul is a Rheumatologist in Atlanta, Georgia. Dr. Kaul is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Rheumatoid Arthritis (RA), MAGIC Syndrome, IgG4-Related Disease, and Light Chain Deposition Disease (LCDD). Dr. Kaul is currently accepting new patients.

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Machua's expertise for a condition
ConditionClose
    • Distinguished
    • Rheumatoid Arthritis (RA)
      Dr. Machua is
      Distinguished
      . Learn about Rheumatoid Arthritis (RA).
      See more Rheumatoid Arthritis (RA) experts
    • Systemic Lupus Erythematosus (SLE)
      Dr. Machua is
      Distinguished
      . Learn about Systemic Lupus Erythematosus (SLE).
      See more Systemic Lupus Erythematosus (SLE) experts
    • Advanced
    • Arthritis
      Dr. Machua is
      Advanced
      . Learn about Arthritis.
      See more Arthritis experts
    • Cutaneous Lupus Erythematosus (CLE)
      Dr. Machua is
      Advanced
      . Learn about Cutaneous Lupus Erythematosus (CLE).
      See more Cutaneous Lupus Erythematosus (CLE) experts
    • Dermatomyositis
      Dr. Machua is
      Advanced
      . Learn about Dermatomyositis.
      See more Dermatomyositis experts
    • Discoid Lupus Erythematosus (DLE)
      Dr. Machua is
      Advanced
      . Learn about Discoid Lupus Erythematosus (DLE).
      See more Discoid Lupus Erythematosus (DLE) experts
    • IgG4-Related Disease
      Dr. Machua is
      Advanced
      . Learn about IgG4-Related Disease.
      See more IgG4-Related Disease experts
    • Light Chain Deposition Disease (LCDD)
      Dr. Machua is
      Advanced
      . Learn about Light Chain Deposition Disease (LCDD).
      See more Light Chain Deposition Disease (LCDD) experts
    View All 19 Advanced Conditions
    • Experienced
    • Ankylosing Spondylitis
      Dr. Machua is
      Experienced
      . Learn about Ankylosing Spondylitis.
      See more Ankylosing Spondylitis experts
    • Axial Spondyloarthritis (AxSpA)
      Dr. Machua is
      Experienced
      . Learn about Axial Spondyloarthritis (AxSpA).
      See more Axial Spondyloarthritis (AxSpA) experts
    • Behcet Disease
      Dr. Machua is
      Experienced
      . Learn about Behcet Disease.
      See more Behcet Disease experts
    • Bursitis
      Dr. Machua is
      Experienced
      . Learn about Bursitis.
      See more Bursitis experts
    • Calcium Pyrophosphate Arthritis
      Dr. Machua is
      Experienced
      . Learn about Calcium Pyrophosphate Arthritis.
      See more Calcium Pyrophosphate Arthritis experts
    • End-Stage Renal Disease (ESRD)
      Dr. Machua is
      Experienced
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.